Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 50 | 0 | 5 | 0 | €705.70 | €766.92 | 8.674% |
| Biogen Inc. | 46 | 1 | 6 | 1 | €205.70 | €294.01 | 42.932% |
| Boston Scientific | 46 | 0 | 10 | 0 | €68.50 | €73.05 | 6.638% |
| Vertex Pharmaceuticals Inc. | 44 | 2 | 8 | 0 | €392.60 | €406.87 | 3.634% |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €139.65 | €236.30 | 69.207% |
| Intuitive Surgical Inc | 34 | 0 | 2 | 0 | €359.00 | €376.15 | 4.778% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 5 | 1 | €903.60 | €957.22 | 5.934% |
| UnitedHealth Group Inc. | 33 | 1 | 2 | 0 | €476.05 | €543.72 | 14.215% |
| Johnson & Johnson | 32 | 1 | 3 | 0 | €139.16 | €196.74 | 41.374% |
| Pfizer Inc. | 31 | 4 | 3 | 0 | €26.01 | €41.10 | 58.028% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €120.80 | €124.93 | 3.418% |
| Tenet Healthcare | 28 | 0 | 6 | 0 | €117.00 | €121.69 | 4.011% |
| Neurocrine Bioscience | 27 | 0 | 6 | 0 | €126.90 | €140.34 | 10.591% |
| Cytokinetics Inc. | 27 | 1 | 3 | 0 | €58.00 | €85.64 | 47.661% |
| Thermo Fisher Scientific Inc. | 26 | 0 | 4 | 0 | €550.70 | €568.09 | 3.158% |
| Edwards Lifesciences Corp. | 26 | 1 | 4 | 0 | €80.49 | €88.14 | 9.501% |
| Amgen Inc. | 25 | 0 | 6 | 0 | €287.90 | €297.31 | 3.269% |
| Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €60.50 | €79.55 | 31.495% |
| Zoetis Inc. A | 23 | 1 | 5 | 0 | €156.94 | €200.06 | 27.474% |
| Jazz Pharmaceuticals plc | 23 | 0 | 3 | 0 | €101.80 | €184.92 | 81.650% |
| Humana Inc. | 23 | 0 | 3 | 0 | €311.60 | €439.88 | 41.167% |
| Stryker Corp. | 23 | 0 | 8 | 0 | €306.90 | €335.03 | 9.165% |
| Trinity Biotech ADR | 22 | 0 | 0 | 0 | €0.41 | - | - |
| HCA Holdings Inc. | 22 | 0 | 5 | 0 | €303.20 | €303.80 | 0.197% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.42 | €28.06 | 81.953% |